<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tumors</journal-id><journal-title-group><journal-title xml:lang="ru">Malignant tumours</journal-title><trans-title-group xml:lang="en"><trans-title>Malignant tumours</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2224-5057</issn><issn pub-type="epub">2587-6813</issn><publisher><publisher-name>Rosoncoweb</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">tumors-300</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ ОНКОУРОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ: ЧЕГО МЫ ДОБИЛИСЬ ЗА 20 ЛЕТ И КУДА ИДЕМ?</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давыдов</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Davidov</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матвеев</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Matveev</surname><given-names>V. B.</given-names></name></name-alternatives><bio xml:lang="ru"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волкова</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Volkova</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черняев</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyaev</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">chercrc@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калинин</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalinin</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комаров</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Komarov</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Российского онкологического научного центра имени Н. Н. Блохина</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Российский национальный исследовательский медицинский университет имени Н.И. Пирогова</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>18</day><month>11</month><year>2016</year></pub-date><volume>0</volume><issue>4s1</issue><fpage>119</fpage><lpage>124</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Давыдов М.И., Матвеев В.Б., Волкова М.И., Черняев В.А., Романов В.А., Калинин С.А., Комаров М.И., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Давыдов М.И., Матвеев В.Б., Волкова М.И., Черняев В.А., Романов В.А., Калинин С.А., Комаров М.И.</copyright-holder><copyright-holder xml:lang="en">Davidov M.I., Matveev V.B., Volkova M.I., Chernyaev V.A., Romanov V.A., Kalinin S.A., Komarov M.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.malignanttumors.org/jour/article/view/300">https://www.malignanttumors.org/jour/article/view/300</self-uri><abstract><p>Хирургическое вмешательство – один из наиболее эффективных  методов лечения онкоурологических заболеваний.</p><p>Залогом достижения удовлетворительных результатов является рациональное определение показаний, сроков и объема операции, основанное на правильной верификации диагноза и адекватном стадировании опухолевого процесса, а также соблюдении основных принципов онкохирургии – абластичности, футлярности и лимфодиссекции в зонах регионарного метастазирования.  Внедрение новых хирургических технологий с одной стороны позволило расширить спектр показаний к выполнению органосохраняющих вмешательств в онкологии, с другой – увеличить долю радикальных операций при местно-распространенных и метастатических злокачественных новообразованиях, ранее считавшихся неоперабельными. Разработка новых реконструктивных методов, а также оперативных подходов к паллиативной помощи больным распространенными опухолями дала возможность существенно улучшить качество жизни данной категории пациентов. Важным этапом в обеспечении хороших послеоперационных результатов имеет скоординированная работа грамотной бригады, включающей анестезиолога, хирурга и реаниматолога. Однако лечение онкоурологических новообразований в ряде случаев требует мультидисциплинарного подхода с привлечением специалистов в области системной цитотоксической и лучевой терапии. Следует подчеркнуть, что залогом своевременного выявления прогрессирования заболевания и возможности его раннего адекватного лечения является тщательное динамическое наблюдение за излеченными пациентами. Таким образом, современное лечение онкоурологических больных возможно только в условиях крупных специализированных центров и не должно осуществляться в клиниках общего профиля.</p></abstract><kwd-group xml:lang="ru"><kwd>рак почки</kwd><kwd>рак предстательной железы</kwd><kwd>рак мочевого пузыря</kwd><kwd>резекция</kwd><kwd>простатэктомия</kwd><kwd>цистэктомия</kwd><kwd>качество жизни</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А. Д., Старинский В. В., Петрова Г. В. Состояние онкологической помощи населению России в 2015 г. Москва, 2016 г.</mixed-citation><mixed-citation xml:lang="en">Каприн А. Д., Старинский В. В., Петрова Г. В. Состояние онкологической помощи населению России в 2015 г. Москва, 2016 г.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Atwell, T.D., et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol, 2013. 200: 461.</mixed-citation><mixed-citation xml:lang="en">Atwell, T.D., et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol, 2013. 200: 461.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Samarasekera D., et al. Percutaneous radiofrequency ablation versus percutaneous cryoablation: long-term outcomes following ablation for renal cell carcinoma. J Urol, 2013. 189: e737.</mixed-citation><mixed-citation xml:lang="en">Samarasekera D., et al. Percutaneous radiofrequency ablation versus percutaneous cryoablation: long-term outcomes following ablation for renal cell carcinoma. J Urol, 2013. 189: e737.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Olweny, E.O., et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol, 2012. 61: 1156.</mixed-citation><mixed-citation xml:lang="en">Olweny, E.O., et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol, 2012. 61: 1156.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Van Poppel, H., et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol, 2011. 59: 543.</mixed-citation><mixed-citation xml:lang="en">Van Poppel, H., et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol, 2011. 59: 543.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Masson-Lecomte, A., et al. A prospective comparison of the treatment of renal cell carcinoma by open or robot-assisted partial nephrectomy. Urol Oncol, 2013. 31: 924.</mixed-citation><mixed-citation xml:lang="en">Masson-Lecomte, A., et al. A prospective comparison of the treatment of renal cell carcinoma by open or robot-assisted partial nephrectomy. Urol Oncol, 2013. 31: 924.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Choi, J.E., et al. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol, 2015. 67: 891.</mixed-citation><mixed-citation xml:lang="en">Choi, J.E., et al. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol, 2015. 67: 891.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Матвеев В. Б., Волкова М. И. и др. Целесообразность и безопасность трансперитонеальной лапароскопической резекции почки при опухолях почечной паренхимы. Оноурология, № 1–2014, стр.25–34.</mixed-citation><mixed-citation xml:lang="en">Матвеев В. Б., Волкова М. И. и др. Целесообразность и безопасность трансперитонеальной лапароскопической резекции почки при опухолях почечной паренхимы. Оноурология, № 1–2014, стр.25–34.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Muramaki, M., et al. Prognostic Factors Influencing Postoperative Development of Chronic Kidney Disease in Patients with Small Renal Tumors who Underwent Partial Nephrectomy. Curr Urol, 2013. 6: 129.</mixed-citation><mixed-citation xml:lang="en">Muramaki, M., et al. Prognostic Factors Influencing Postoperative Development of Chronic Kidney Disease in Patients with Small Renal Tumors who Underwent Partial Nephrectomy. Curr Urol, 2013. 6: 129.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rais-Bahrami, S., et al. Off-clamp versus complete hilar control laparoscopic partial nephrectomy: comparison by clinical stage. BJU Int, 2012. 109: 1376.</mixed-citation><mixed-citation xml:lang="en">Rais-Bahrami, S., et al. Off-clamp versus complete hilar control laparoscopic partial nephrectomy: comparison by clinical stage. BJU Int, 2012. 109: 1376.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bekema, H.J., et al. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol, 2013. 64: 799.</mixed-citation><mixed-citation xml:lang="en">Bekema, H.J., et al. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol, 2013. 64: 799.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fokas, E., et al. Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients. Strahlenther Onkol, 2010. 186: 210.</mixed-citation><mixed-citation xml:lang="en">Fokas, E., et al. Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients. Strahlenther Onkol, 2010. 186: 210.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Staehler, M.D., et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol, 2010. 28: 543.</mixed-citation><mixed-citation xml:lang="en">Staehler, M.D., et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol, 2010. 28: 543.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Amiraliev A., et al. Treatment strategy in patients with pulmonary metastases of renal cell cancer. Int Cardio Thor Surgery 2012: S20.</mixed-citation><mixed-citation xml:lang="en">Amiraliev A., et al. Treatment strategy in patients with pulmonary metastases of renal cell cancer. Int Cardio Thor Surgery 2012: S20.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yakoubi, R., et al. Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. Eur J Surg Oncol, 2014. 40: 1629.</mixed-citation><mixed-citation xml:lang="en">Yakoubi, R., et al. Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. Eur J Surg Oncol, 2014. 40: 1629.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ni, S., et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. Eur Urol, 2012. 61: 1142.</mixed-citation><mixed-citation xml:lang="en">Ni, S., et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. Eur Urol, 2012. 61: 1142.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">N. Mottet et al. EAU Guidelines on prostate cancer, 2016.</mixed-citation><mixed-citation xml:lang="en">N. Mottet et al. EAU Guidelines on prostate cancer, 2016.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bianco, F.J., Jr., et al. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (?trifecta?). Urology, 2005. 66: 83.</mixed-citation><mixed-citation xml:lang="en">Bianco, F.J., Jr., et al. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (?trifecta?). Urology, 2005. 66: 83.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Briganti, A., et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol, 2012. 61: 480.</mixed-citation><mixed-citation xml:lang="en">Briganti, A., et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol, 2012. 61: 480.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mattei, A., et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol, 2008. 53: 118.</mixed-citation><mixed-citation xml:lang="en">Mattei, A., et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol, 2008. 53: 118.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Joniau, S., et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol, 2013. 63: 450.</mixed-citation><mixed-citation xml:lang="en">Joniau, S., et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol, 2013. 63: 450.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ramsay, C., et al. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess, 2012. 16: 1.</mixed-citation><mixed-citation xml:lang="en">Ramsay, C., et al. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess, 2012. 16: 1.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gontero, P., et al. Nerve-sparing radical retropubic prostatectomy: techniques and clinical considerations. Prostate Cancer Prostatic Dis, 2005. 8: 133.</mixed-citation><mixed-citation xml:lang="en">Gontero, P., et al. Nerve-sparing radical retropubic prostatectomy: techniques and clinical considerations. Prostate Cancer Prostatic Dis, 2005. 8: 133.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Fahmy, W.E., et al. Cryosurgery for prostate cancer. Arch Androl, 2003. 49: 397.</mixed-citation><mixed-citation xml:lang="en">Fahmy, W.E., et al. Cryosurgery for prostate cancer. Arch Androl, 2003. 49: 397.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Han, K.R., et al. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int, 2004. 93: 14.</mixed-citation><mixed-citation xml:lang="en">Han, K.R., et al. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int, 2004. 93: 14.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ramsay, C.R., et al. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. Health Technol Assess, 2015. 19: 1.</mixed-citation><mixed-citation xml:lang="en">Ramsay, C.R., et al. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. Health Technol Assess, 2015. 19: 1.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Madersbacher, S., et al. High-energy shockwaves and extracorporeal high-intensity focused ultrasound. J Endourol, 2003. 17: 667.</mixed-citation><mixed-citation xml:lang="en">Madersbacher, S., et al. High-energy shockwaves and extracorporeal high-intensity focused ultrasound. J Endourol, 2003. 17: 667.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Aus, G. Current status of HIFU and cryotherapy in prostate cancer – a review. Eur Urol, 2006. 50: 927.</mixed-citation><mixed-citation xml:lang="en">Aus, G. Current status of HIFU and cryotherapy in prostate cancer – a review. Eur Urol, 2006. 50: 927.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Mouraviev, V., et al. Pathologic basis of focal therapy for early- stage prostate cancer. Nat Rev Urol, 2009. 6: 205.</mixed-citation><mixed-citation xml:lang="en">Mouraviev, V., et al. Pathologic basis of focal therapy for early- stage prostate cancer. Nat Rev Urol, 2009. 6: 205.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Mandel, P., et al. Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta- analysis. Urol Oncol, 2014. 32: 1184.</mixed-citation><mixed-citation xml:lang="en">Mandel, P., et al. Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta- analysis. Urol Oncol, 2014. 32: 1184.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Gross, T., et al. Orthotopic ileal bladder substitution in women: factors influencing urinary incontinence and hypercontinence. Eur Urol, 2015. 68: 664.</mixed-citation><mixed-citation xml:lang="en">Gross, T., et al. Orthotopic ileal bladder substitution in women: factors influencing urinary incontinence and hypercontinence. Eur Urol, 2015. 68: 664.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Orihashi, K., et al. Deep hypothermic circulatory arrest for resection of renal tumor in the inferior vena cava: beneficial or deleterious? Circ J, 2008. 72: 1175.</mixed-citation><mixed-citation xml:lang="en">Orihashi, K., et al. Deep hypothermic circulatory arrest for resection of renal tumor in the inferior vena cava: beneficial or deleterious? Circ J, 2008. 72: 1175.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Давыдов М. И., Матвеев В. Б., Волкова М. И. и др. Факторы прогноза непосредственных результатов тромбэктомии у больных раком почки с опухолевым венозным тромбозом. Онкоурология, М.–2014-№ 3, стр.31–39.</mixed-citation><mixed-citation xml:lang="en">Давыдов М. И., Матвеев В. Б., Волкова М. И. и др. Факторы прогноза непосредственных результатов тромбэктомии у больных раком почки с опухолевым венозным тромбозом. Онкоурология, М.–2014-№ 3, стр.31–39.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Матвеев В. Б., Волкова М. И., Черняев В. А. и др. Забрюшинная лимфаденэктомия после индукционной химиотерапии при диссеминированных несеминомных герминогенных опухолях яичка. Онкоурология, М.– 2010 – № 1, стр.52–58.</mixed-citation><mixed-citation xml:lang="en">Матвеев В. Б., Волкова М. И., Черняев В. А. и др. Забрюшинная лимфаденэктомия после индукционной химиотерапии при диссеминированных несеминомных герминогенных опухолях яичка. Онкоурология, М.– 2010 – № 1, стр.52–58.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
